Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

NCT04773665 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: VBI-2902a
BIOLOGICAL: Placebo
BIOLOGICAL: VBI-2905a

Sponsor

VBI Vaccines Inc.